Navigation Links
Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
Date:10/27/2011

p>

$   411,681$
-$   411,681$   396,104$
-$   396,1044%4%Cost of sales

285,1071,022

(a)

284,085270,512802

(a)

269,7105%5%Gross profit

126,5741,022127,596125,592802126,3941%1%Operating expenses

62,0911,222

(a)

60,86954,2731,312

(a)

52,96114%15%Operating income

$
4,483$
2,244$
,727$
71,319$
2,114$
73,433-10%-9%Selected ratios as a percentage of net sales   Gross profit

30.7%31.0%31.7%31.9%   Operating expenses

15.1%14.8%13.7%13.4%   Operating income

15.7%16.2%18.0%18.5%Three Months EndedNutritionalsSeptember 24, 2011September 25, 2010% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales

$   119,861$
-$   119,861$   122,684$
-$   122,684-2%-2%Cost of sales

89,2385,850

(a)

83,38884,2943,000

(a)

81,2946%3%Gross profit

30,6235,85036,47338,3903,00041,390-20%-12%Operating expenses

21,5583,615

(a)

17,94320,3112,801

(a)

17,5106%2%Operating income

$
9,065$
9,465$
8,530$
8,079$
5,801$
23,880-50%-22%Selected ratios as a percentage of net sales   Gross profit

25.5%30.4%31.3%33.7%   Operating expenses

18.0%15.0%16.6%14.3%   Operating income

7.6%15.5%14.7%19.5%Three Months EndedRx PharmaceuticalsSeptember 24, 2011September 25, 2010% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales

$   127,627$
-$   127,627$
9,333$
-$
9,33384%84%Cost of sales

84,79134,532

(a,b)

50,25941,5612,459

(a)

39,102104%29%Gross profit

42,83634,53277,36827,7722,45930,23154%156%Operating expenses

15,993(344)

(c,d)

16,33710,017-10,01760%63%Operating income

$
26,843$
34,188$
,
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  According to their CEO, Rob Bohacs ... is going through a complete transformation with highly ... the current clinical trial management process isn,t configured ... trials, which will ultimately drive the prescription cancer ... has been recognized by the National Cancer Institute as ...
(Date:9/30/2014)... 2014   Easy Breathe , the fastest growing ... that it now offers the revolutionary AirSense ... first sleep apnea therapy devices with internal cellular modems.  ... track and share real-time data on each user,s quality ... therapy.  In addition, the internal modem allows the CPAP ...
(Date:9/30/2014)... , Sept. 30, 2014 Valeant Pharmaceuticals International, ... today announced that the company,s Bridgewater, New ... the U.S. Food and Drug Administration (FDA) relating to ... with regards to Sculptra Aesthetic injectable, which was divested ... to the management of Valeant,s contract manufacturers (rather than ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2
... Today Brainlab announced the 500th sale of its ... The scale of uptake highlights physicians continued focus on ... their ongoing investment in ensuring access to advanced radiation ... system, first developed almost a decade ago, has been ...
... 16, 2012 On January 9, 2012, Questcor ... from an individual representing herself to be associated ... individual requested that the Company provide responses to ... January 10, 2012.  Due to management,s schedule, the ...
Cached Medicine Technology:Brainlab ExacTrac® System Achieves Major Sales Milestone 2Questcor Pharmaceuticals Responds to Questions From Investor Blog 2Questcor Pharmaceuticals Responds to Questions From Investor Blog 3Questcor Pharmaceuticals Responds to Questions From Investor Blog 4Questcor Pharmaceuticals Responds to Questions From Investor Blog 5Questcor Pharmaceuticals Responds to Questions From Investor Blog 6Questcor Pharmaceuticals Responds to Questions From Investor Blog 7Questcor Pharmaceuticals Responds to Questions From Investor Blog 8Questcor Pharmaceuticals Responds to Questions From Investor Blog 9Questcor Pharmaceuticals Responds to Questions From Investor Blog 10Questcor Pharmaceuticals Responds to Questions From Investor Blog 11Questcor Pharmaceuticals Responds to Questions From Investor Blog 12Questcor Pharmaceuticals Responds to Questions From Investor Blog 13Questcor Pharmaceuticals Responds to Questions From Investor Blog 14Questcor Pharmaceuticals Responds to Questions From Investor Blog 15Questcor Pharmaceuticals Responds to Questions From Investor Blog 16Questcor Pharmaceuticals Responds to Questions From Investor Blog 17
(Date:9/30/2014)... September 30, 2014 FDA-approved injectable ... Poly-L-lactic acid) are used in several procedures that ... in patients, but are primarily used for wrinkle ... rejuvenation—in particular, these fillers are being used as ... restoring smoother skin in the hands. (1) (2) ...
(Date:9/30/2014)... Healthpointe is proud to announce that Dr. ... ankle reconstruction surgeries to assist patients with severe orthopedic ... in the diagnosis and treatment of sports medicine, and ... trained to perform advanced Foot and Ankle Reconstruction to ... also fluent in Spanish. , Reconstructive surgical procedures for ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 To mark ... Editorial Board of Living with a Disability magazine ... light on hematological disorders as disabling conditions. ... more than a diagnosis to establish a disability related ... thrombocytomenia, myelofibrosis, hereditary telangiectasia, coagulation defects, polycythemia vera, and ...
(Date:9/30/2014)... 2014 Jiwa Law Corporation, a personal injury ... will now be offering free consultation for personal injury claims ... law firm for the first time to meet the Vancouver ... the opportunity to understand what their rights are. The experts ... client to explain to them what the law firm can ...
(Date:9/30/2014)... Coast Dental and Orthodontics is proud ... located at 1010 Shaw Avenue in Clovis, CA. The ... , and specialty dental care including orthodontics, endodontics, periodontics, ... convenient dental care, our Clovis dentists also strive to ... Dental at 559-777-6113 to schedule an appointment. , Our ...
Breaking Medicine News(10 mins):Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 2Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 3Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 4Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 3Health News:Jiwa Law Corporation Now Offers Personal Injury Consultation Without Any Charge 2Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3
... Ad For Containing,Inappropriate, Content While Original PP:GG Content ... "It is outrageous that,YouTube would black-out our video ... while it continues to carry the original Planned,Parenthood ... Life League., The "inappropriate nature" cited by ...
... Promising results need to be replicated in larger study, ... A drug originally designed to combat cancer that is ... rheumatoid arthritis and lupus might also work against a ... published in the Feb. 14 issue of the ...
... Feb. 13 DaVita Inc.,(NYSE: DVA ) today ... 2007. Net income for the three months ended December ... compared to $74.1 million, or $0.70 per,share, for the ... Net income for the year ended December 31, ...
... February 13, 2008 Eight outstanding cancer care providers ... chosen to receive the 2008 American Cancer Society Lane ... prize for cancer caring. The Lane W. Adams Quality ... difference through innovation, leadership, and consistent excellence in providing ...
... Feb. 13 NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), ... United States, today announced,financial results for its fourth quarter and ... -- Full year revenues grew 65% to $151.7 million from ... Organic revenue grew $21.4 million, or 23% ...
... WALTHAM, Mass., Feb. 13 Inverness Medical,Innovations, Inc. ... rapid point-of-care,diagnostic products, today announced that it will ... 20, 2008. The Company will,also host a conference ... that,date to discuss these results and other corporate ...
Cached Medicine News:Health News:ICYMI: YouTube Censors American Life League 2Health News:Cancer Drug Works Against MS in Early Trial 2Health News:Cancer Drug Works Against MS in Early Trial 3Health News:DaVita 4th Quarter 2007 Results 2Health News:DaVita 4th Quarter 2007 Results 3Health News:DaVita 4th Quarter 2007 Results 4Health News:DaVita 4th Quarter 2007 Results 5Health News:DaVita 4th Quarter 2007 Results 6Health News:DaVita 4th Quarter 2007 Results 7Health News:DaVita 4th Quarter 2007 Results 8Health News:DaVita 4th Quarter 2007 Results 9Health News:DaVita 4th Quarter 2007 Results 10Health News:DaVita 4th Quarter 2007 Results 11Health News:DaVita 4th Quarter 2007 Results 12Health News:DaVita 4th Quarter 2007 Results 13Health News:DaVita 4th Quarter 2007 Results 14Health News:DaVita 4th Quarter 2007 Results 15Health News:DaVita 4th Quarter 2007 Results 16Health News:DaVita 4th Quarter 2007 Results 17Health News:American Cancer Society honors exemplary cancer caregivers 2Health News:American Cancer Society honors exemplary cancer caregivers 3Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 2Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 3Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 4Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 5Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 6Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 7Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 8Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 9Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 10Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 11Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 12Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 13Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 14Health News:NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance 15
The VPAP III ST is a complete system solution for SDB, providing comfortable and effective bilevel treatment with additional treatment modes. The VPAP III ST is an effective business solution for cli...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
... The BiPAP Pro with Bi-Flex bi-level ... time that the BiPAP Pro takes to ... includes Digital Auto-Trak Sensitivity™ which automatically triggers ... expiratory pressures based on the patients breathing ...
... Electrophoresis System (PGGE) is designed to ... density lipoproteins (LDL) and high density ... using nondenaturing pore gradient gel electrophoresis. ... short DNA sequencing runs. Temperature control ...
Medicine Products: